S
Shameera
About Shameera
Data last updated:
Shameera is a Managing Director at Ethiall Pharmaceuticals Private Limited (since 2022) and Managing Director at Le Medi Forte Private Limited (since 2022). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹13.69 Cr; the largest is Ethiall Pharmaceuticals Private Limited at ₹9.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ethiall Pharmaceuticals Private Limited U24290KA2022PTC157158 | Managing Director | 28 Jan 2022 | 2022 | ₹9.64 Cr (FY 2025) | Active |
| Le Medi Forte Private Limited U24290KL2022PTC073783 | Managing Director | 03 Feb 2022 | 2022 | ₹4.05 Cr (FY 2025) | Active |
Board colleagues of Shameera
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdul Jaleel Angadi Karanakath | 10537246 | Ethiall Pharmaceuticals Private Limited | Director |
| Budala John Mercy | 10537615 | Ethiall Pharmaceuticals Private Limited | Director |
| Cheriyeri Peediyekkal Iza Fathima | 11148482 | Ethiall Pharmaceuticals Private Limited | Director |
| Fidha Fathima | 09483537 | Ethiall Pharmaceuticals Private Limited | Director |
| Rahmath | 10537870 | Ethiall Pharmaceuticals Private Limited | Director |
| Wasim Mohamed | 09491636 | Le Medi Forte Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shameera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shameera
Shameera currently holds 2 directorships: Ethiall Pharmaceuticals Private Limited (Managing Director, since 28 Jan 2022, revenue ₹9.64 Cr (FY 2025)); Le Medi Forte Private Limited (Managing Director, since 03 Feb 2022, revenue ₹4.05 Cr (FY 2025)).
Shameera was first appointed on 28 Jan 2022 as Managing Director at Ethiall Pharmaceuticals Private Limited.
The 2 current companies of Shameera that report revenue have a combined latest revenue of ₹13.69 Cr: Ethiall Pharmaceuticals Private Limited ₹9.64 Cr (FY 2025); Le Medi Forte Private Limited ₹4.05 Cr (FY 2025).
The current boards of Shameera's companies include Abdul Jaleel Angadi Karanakath (Ethiall Pharmaceuticals Private Limited), Budala John Mercy (Ethiall Pharmaceuticals Private Limited), Cheriyeri Peediyekkal Iza Fathima (Ethiall Pharmaceuticals Private Limited), Fidha Fathima (Ethiall Pharmaceuticals Private Limited), Rahmath (Ethiall Pharmaceuticals Private Limited), Wasim Mohamed (Le Medi Forte Private Limited).